MX361731B - Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk. - Google Patents
Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk.Info
- Publication number
- MX361731B MX361731B MX2013009380A MX2013009380A MX361731B MX 361731 B MX361731 B MX 361731B MX 2013009380 A MX2013009380 A MX 2013009380A MX 2013009380 A MX2013009380 A MX 2013009380A MX 361731 B MX361731 B MX 361731B
- Authority
- MX
- Mexico
- Prior art keywords
- cell activity
- diagnosing cancer
- diagnostic kit
- activity measurement
- cancer
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 238000005259 measurement Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 title 1
- 210000004369 blood Anatomy 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 210000000822 natural killer cell Anatomy 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/15—Natural-killer [NK] cells; Natural-killer T [NKT] cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5434—IL-12
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5443—IL-15
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110012983A KR20120093002A (ko) | 2011-02-14 | 2011-02-14 | Ｎｋ 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트 |
| PCT/IB2012/000259 WO2012110878A2 (en) | 2011-02-14 | 2012-02-10 | Method of diagnosing cancer and diagnosis kit using measurement of nk cell activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013009380A MX2013009380A (es) | 2013-12-16 |
| MX361731B true MX361731B (es) | 2018-12-14 |
Family
ID=46672988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013009380A MX361731B (es) | 2011-02-14 | 2012-02-10 | Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11442069B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2676139B1 (cg-RX-API-DMAC7.html) |
| JP (5) | JP6629497B2 (cg-RX-API-DMAC7.html) |
| KR (3) | KR20120093002A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103370622B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2012219184A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013020454B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2826053C (cg-RX-API-DMAC7.html) |
| CL (1) | CL2013002361A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2676139T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA038959B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2797549T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL227952B (cg-RX-API-DMAC7.html) |
| MX (1) | MX361731B (cg-RX-API-DMAC7.html) |
| MY (1) | MY175351A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2635194C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG192247A1 (cg-RX-API-DMAC7.html) |
| TW (2) | TWI681191B (cg-RX-API-DMAC7.html) |
| UA (1) | UA120697C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012110878A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120093002A (ko) | 2011-02-14 | 2012-08-22 | (주)에이티젠 | Ｎｋ 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트 |
| JP6549570B2 (ja) | 2013-11-05 | 2019-07-24 | エージェンシー フォー サイエンス， テクノロジー アンド リサーチ | 膀胱癌バイオマーカー |
| JP6073417B2 (ja) * | 2015-06-26 | 2017-02-01 | チャ バイオテック カンパニー リミテッド | 自然殺害細胞増殖方法、及び自然殺害細胞増殖用の組成物 |
| KR101926166B1 (ko) * | 2016-05-24 | 2018-12-06 | 재단법인 아산사회복지재단 | 수용체 시너지 활성을 이용한 nk 세포의 활성도 검사 방법 및 이를 이용한 nk 세포의 활성도가 관련된 질환의 진단 방법 |
| WO2017204446A2 (ko) * | 2016-05-24 | 2017-11-30 | 울산대학교 산학협력단 | 수용체 시너지 활성을 이용한 nk 세포의 활성도 검사 방법 및 이를 이용한 nk 세포의 활성도가 관련된 질환의 진단 방법 |
| CN106085958A (zh) * | 2016-08-04 | 2016-11-09 | 英普乐孚生物技术(上海)有限公司 | 一种nk细胞的制备方法 |
| CN106222140A (zh) * | 2016-08-04 | 2016-12-14 | 英普乐孚生物技术(上海)有限公司 | 一种nk细胞无血清培养基及其配制方法 |
| CN107686828A (zh) * | 2016-08-04 | 2018-02-13 | 英普乐孚生物技术(上海)有限公司 | 一种nk细胞无血清培养基 |
| KR102573778B1 (ko) | 2017-02-17 | 2023-08-31 | 브리스톨-마이어스 스큅 컴퍼니 | 알파-시뉴클레인에 대한 항체 및 그의 용도 |
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| KR102090698B1 (ko) * | 2017-08-24 | 2020-04-23 | 연세대학교 산학협력단 | 암의 진단, 모니터링, 또는 예후 예측을 위해 생체 외 인터페론-감마의 양을 측정하는 방법 |
| MY199514A (en) | 2018-02-01 | 2023-11-02 | Nkmax Co Ltd | Method of producing natural killer cells and composition for treating cancer |
| AU2020221310B2 (en) * | 2019-02-14 | 2025-10-16 | Research Institute At Nationwide Children's Hospital | Use of a stimulating agent to assay immune cell potency |
| WO2021041399A1 (en) * | 2019-08-29 | 2021-03-04 | Board Of Regents, The University Of Texas System | Cell cryopreservation medium |
| JP2022550743A (ja) * | 2019-09-25 | 2022-12-05 | リートー ラボラトリーズ カンパニー リミテッド | 組換えインターロイキン－１５アナログ |
| JP2023505102A (ja) * | 2019-11-29 | 2023-02-08 | エヌケーマックス カンパニー リミテッド | ナチュラルキラー細胞を製造する方法およびその組成物 |
| CN113533729B (zh) * | 2021-06-15 | 2024-09-06 | 北京大学人民医院 | 一种鉴定aml患者骨髓中nk细胞耗竭的研究方法及其应用 |
| WO2023111569A1 (en) * | 2021-12-17 | 2023-06-22 | University Of Kent | Sequences and methods for production of recombinant biological molecules in vesicles |
| KR20230156518A (ko) | 2022-05-06 | 2023-11-14 | (주)다이오진 | 엑소좀 내의 인터페론 감마 유전자 측정을 이용한 암 조기 진단 방법 및 진단 키트 |
| CN115247149B (zh) * | 2022-08-22 | 2023-06-16 | 华域生物科技(天津)有限公司 | 适用于nk细胞的培养基组合物及培养方法 |
| CN115855779A (zh) * | 2023-01-18 | 2023-03-28 | 山东康华生物医疗科技股份有限公司 | 一种定量检测nk细胞活性的磁微粒化学发光试剂盒及其检测方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT89121A (pt) * | 1987-12-04 | 1989-12-29 | Du Pont | Processo para a preparacao de interleuquina-2 imobilizada e interleuquina-2 contendo uma extensao no terminal-carboxilo com actividade de interleuquina-2 natural |
| ES2167373T3 (es) * | 1993-08-09 | 2002-05-16 | Edward Baral | Un metodo para la sensibilizacion de celulas cancerosas con respecto a la lisis mediada por celulas asesinas. |
| AU695129B2 (en) * | 1995-02-06 | 1998-08-06 | Genetics Institute, Llc | Formulations for IL-12 |
| US20060057651A1 (en) * | 2000-12-08 | 2006-03-16 | Bowdish Katherine S | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| JP3995248B2 (ja) | 2001-08-13 | 2007-10-24 | 準二郎 土山 | エプスタインバーウイルス陰性のｎｋ細胞株 |
| EP1451217A4 (en) * | 2001-11-20 | 2005-10-12 | Atgen Co Ltd | NEW PEPTIDES PROVIDING ENVIRONMENTAL RESISTANCE, AND FUSION PROTEINS CONTAINING THOSE PEPTIDES |
| EP1494712A4 (en) | 2002-03-26 | 2006-06-14 | Centocor Inc | MULTIPLE SCLEROSIS RELATED PROTEINS, COMPOSITIONS, PROCESSES AND APPLICATIONS DERIVED FROM IMMUNOGLOBULIN |
| JP2004305095A (ja) | 2003-04-07 | 2004-11-04 | Limuloid Science Kk | 細胞活性化検出方法 |
| CN1297567C (zh) * | 2003-06-13 | 2007-01-31 | 马菁 | 具有抗肿瘤功能的双功能融合蛋白及其制备方法和应用 |
| US7534585B2 (en) | 2003-07-21 | 2009-05-19 | Transgene S.A. | Multifunctional cytokines |
| JP2007501618A (ja) | 2003-08-08 | 2007-02-01 | アバニール・ファーマシューティカルズ | タンパク質輸送の選択的薬理学的阻害、および関連した、ヒト疾患を治療する方法 |
| MXPA06005104A (es) | 2003-11-05 | 2007-01-25 | Palingen Inc | Citotoxicidad de celulas b aumentada en anticuerpos de enlace a cdim. |
| US20050203010A1 (en) | 2003-11-14 | 2005-09-15 | Atgen Co., Ltd. | Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| KR100565764B1 (ko) * | 2005-05-02 | 2006-03-28 | (주)에이티젠 | 환경 스트레스에 내성을 부여하는 신규한 펩타이드 및 이를포함하는 융합 단백질 |
| JP4653465B2 (ja) | 2004-10-25 | 2011-03-16 | 泰信 小林 | ナチュラルキラー細胞の増殖促進方法およびそれに用いる培養組成物 |
| EP1901766A2 (en) * | 2005-04-08 | 2008-03-26 | Morningside Venture Investments Limited | Use of fril proteins for reducing the production of pro-inflammatory cytokines |
| WO2008013975A2 (en) * | 2006-07-28 | 2008-01-31 | The Research Foundation Of State University Of New York | Methods and kits for measurement of lymphocyte function |
| WO2008070647A1 (en) * | 2006-12-07 | 2008-06-12 | Wyeth | Methods and compositions for assessing il-12 or the neutralization of il-12 in a sample |
| US20100189723A1 (en) | 2007-01-11 | 2010-07-29 | Peter Andreas Nicolai Reumert Wagtmann | Anti-kir antibodies, formulations, and uses thereof |
| EP2048237A1 (en) | 2007-10-05 | 2009-04-15 | Avir Green Hills Biotechnology Research Development Trade Ag | Replication deficient Influenza virus for the expression of heterologous sequences |
| KR20120093002A (ko) | 2011-02-14 | 2012-08-22 | (주)에이티젠 | Ｎｋ 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트 |
-
2011
- 2011-02-14 KR KR1020110012983A patent/KR20120093002A/ko active Pending
-
2012
- 2012-02-10 CA CA2826053A patent/CA2826053C/en active Active
- 2012-02-10 JP JP2013553044A patent/JP6629497B2/ja active Active
- 2012-02-10 EA EA201391187A patent/EA038959B1/ru unknown
- 2012-02-10 RU RU2013141487A patent/RU2635194C2/ru active
- 2012-02-10 BR BR112013020454-0A patent/BR112013020454B1/pt not_active IP Right Cessation
- 2012-02-10 UA UAA201310947A patent/UA120697C2/uk unknown
- 2012-02-10 MX MX2013009380A patent/MX361731B/es active IP Right Grant
- 2012-02-10 SG SG2013058375A patent/SG192247A1/en unknown
- 2012-02-10 KR KR1020137006311A patent/KR101341538B1/ko active Active
- 2012-02-10 CN CN201280008685.3A patent/CN103370622B/zh active Active
- 2012-02-10 US US13/985,301 patent/US11442069B2/en active Active
- 2012-02-10 WO PCT/IB2012/000259 patent/WO2012110878A2/en not_active Ceased
- 2012-02-10 DK DK12747246.2T patent/DK2676139T3/da active
- 2012-02-10 ES ES12747246T patent/ES2797549T3/es active Active
- 2012-02-10 MY MYPI2013002917A patent/MY175351A/en unknown
- 2012-02-10 KR KR1020137031527A patent/KR101438573B1/ko active Active
- 2012-02-10 EP EP12747246.2A patent/EP2676139B1/en active Active
- 2012-02-10 AU AU2012219184A patent/AU2012219184A1/en not_active Abandoned
- 2012-02-14 TW TW106103526A patent/TWI681191B/zh not_active IP Right Cessation
- 2012-02-14 TW TW101104742A patent/TWI668445B/zh active
-
2013
- 2013-08-14 IL IL227952A patent/IL227952B/en active IP Right Grant
- 2013-08-14 CL CL2013002361A patent/CL2013002361A1/es unknown
-
2017
- 2017-03-31 JP JP2017069908A patent/JP6798922B2/ja active Active
- 2017-04-20 AU AU2017202628A patent/AU2017202628B2/en not_active Ceased
-
2019
- 2019-07-05 JP JP2019126244A patent/JP2019207242A/ja active Pending
-
2021
- 2021-12-06 JP JP2021197948A patent/JP2022043119A/ja not_active Withdrawn
-
2022
- 2022-03-10 US US17/691,391 patent/US12379384B2/en active Active
-
2023
- 2023-05-08 JP JP2023076634A patent/JP7660605B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX361731B (es) | Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk. | |
| BR112013010952A2 (pt) | sistemas de rmn e métodos para a detecção rápida de analisados | |
| EP2831280A4 (en) | PROCESS FOR THE PROGNOSIS, DIAGNOSIS AND TREATMENT OF IDIOPATHIC LUNG FIBROSIS | |
| EA201390149A1 (ru) | Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток | |
| MX361058B (es) | Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero. | |
| BR112014009643A2 (pt) | métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretal | |
| FR2965360B1 (fr) | Procede de diagnostic in situ de batteries par spectroscopie d'impedance electrochimique | |
| EA201500080A1 (ru) | Способ in vitro диагностирования и мониторинга рака | |
| MX2013000916A (es) | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. | |
| WO2012173976A3 (en) | Methods and apparatus for assessing activity of an organ and uses thereof | |
| EP2931133A4 (en) | ULTRASONIC TERMINAL CAP AND METHOD FOR TESTING AN ULTRASONIC SOUND AND ULTRASOUND DIAGNOSTIC SYSTEM THEREFOR | |
| WO2016044338A3 (en) | Methods and systems for diagnosing sleep disorders | |
| WO2012065025A3 (en) | Prostate cancer point of care diagnostics | |
| HK1259001A1 (zh) | 癌症的预後和诊断方法 | |
| WO2014158287A3 (en) | A method for improving disease diagnosis using measured analytes | |
| NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
| HK1219308A1 (zh) | 使用来自母体血液的胎儿细胞捕获的胎儿诊断学 | |
| MX381530B (es) | Método in vitro para el diagnóstico de la enfermedad de niemann-pick. | |
| BR112014007007A2 (pt) | método de diferenciação precoce, método de diagnóstico de fibrilação, uso de troponina cardíaca, dispositivo de diferenciação e dispositivo de diagnóstico | |
| BR112015014232A2 (pt) | lesão renal aguda | |
| BR112014031957A2 (pt) | bag3 como soro bioquímico e marcador de tecido | |
| WO2014087255A3 (en) | Systems and methods for monitoring biological fluids | |
| WO2013167727A3 (en) | Method for determining arthritis relapse risk | |
| WO2012008747A3 (ko) | 피부 진단 방법 및 키트 | |
| TH101590B (th) | วิธีการในการวินิจฉัยโรคมะเร็งและชุดตรวจวินิจฉัยโดยการใช้การตรวจวัดฤทธิ์ของ nk เซลล์ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |